|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.740 USD | -1.40% |
|
+2.79% | -5.38% |
| Jan. 05 | Cybin Inc.(NasdaqGM:HELP) added to NASDAQ Composite Index | CI |
| Jan. 05 | Helus Pharma begins Nasdaq trading, advances mental health therapies | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 392M | - | - | - | - | - |
| 49.52B | |||||
| 44.32B | |||||
| 33.97B | - | ||||
| 26.62B | - | ||||
| 20.71B |
- Stock Market
- Equities
- HELP Stock
- Charts Cybin Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
